NEUROPEPTIDE RESEARCH

DSIP: Delta Sleep-Inducing Peptide Research

Velox Peptides Research Team·Published May 2026·5 min read
CAS Number
62568-57-4
Peptide Length
9 amino acids
Origin
Endogenous neuropeptide
HPLC Purity
≥98.7% (batch-verified)
For in vitro research use only. DSIP is supplied solely as a research reagent for in vitro use and is not for human or veterinary consumption.

What is DSIP?

DSIP (short for Delta Sleep-Inducing Peptide) is a peptide — a short chain of amino acids, the building blocks that make up proteins. It is made of 9 of these building blocks (so scientists call it a nonapeptide; "nona" just means nine), and its order is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. In animal studies, researchers have looked at how it relates to deep sleep and to how the body handles stress. It is sold only as a research reagent (a chemical for lab tests), for in vitro use (test-tube / lab work only) — never for use in humans or animals.

Scientists first found DSIP in the blood of rabbits during sleep experiments. Its name comes from "delta waves" — the slow brain waves your brain makes during deep sleep. DSIP is an endogenous peptide, which just means the body makes it naturally. That makes it a useful tool for studying how small peptides take part in sleep and in the body's hormone signals.

Even after many years of study, no one is fully sure exactly how DSIP works or which receptor (the "lock" a molecule fits into to send a signal) it acts on. One review even called it a "still unresolved riddle." That unanswered question is part of why scientists keep studying it.

Sleep modulation and stress-response research

DSIP research covers three main areas: how it relates to deep sleep, how it links to sleep-time hormone signals, and a wider role in stress and keeping the body balanced. All of this is studied even though scientists still don't fully understand how it works.

Slow-wave (delta) sleep modulation

The thing DSIP is best known for in research is its link to slow-wave (delta) sleep — the deepest stage of sleep. In rat and rabbit studies, DSIP and stronger lab-made copies of it were linked to more deep sleep and more REM sleep (the dream stage). When scientists blocked the animal's own DSIP using an antiserum (a substance that grabs and neutralises a specific molecule), the usual rebound of extra deep sleep after sleep loss was reduced. This suggests DSIP takes part in the body's natural control of deep sleep, rather than just knocking the animal out.

Sleep-related growth hormone and neuroendocrine signalling

DSIP has also been studied for its links to hormones that get released during sleep, including growth hormone (GH), which helps the body grow and repair. Research has described DSIP affecting a signal called somatostatin through a dopamine-based pathway — one way a sleep-linked peptide could connect to the growth-hormone system. This makes it a handy tool for studying how sleep and hormone release are tied together.

Stress, antioxidant and homeostatic effects

Apart from sleep, DSIP has been looked at for how it relates to calming the body's stress response, to antioxidant activity (mopping up cell-damaging particles), and to keeping the body's internal systems in balance, all in animal studies. Together, these make DSIP a research reagent useful for studying how a peptide can affect several of the body's natural rhythms.

Key research findings

The following peer-reviewed studies are representative of the preclinical DSIP literature and are summarised for scientific reference only.

Slow-wave sleep & GH release
Evidence for a role of delta-sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat. 1988

Reported that DSIP was associated with slow-wave sleep and with the growth-hormone release that accompanies it in rats — a foundational link between the peptide, sleep state and neuroendocrine output.

PMID: 3368469

Slow-wave & paradoxical sleep
The phosphorylated analogue of DSIP enhances slow-wave sleep and paradoxical sleep in unrestrained rats. 1989

Reported that a stabilised (phosphorylated) DSIP analogue significantly increased both slow-wave and paradoxical (REM) sleep during nocturnal intracerebroventricular infusion in rats.

PMID: 2496423

Comparative hypnogenic effects
The hypnogenic effects of DSIP analogues: a comparative study in rabbits and rats. 1992

Compared DSIP analogues across two species, reporting that more stable analogues augmented slow-wave and paradoxical sleep within defined windows of the recording period.

PMID: 1455954

Research context

DSIP sits within the neuropeptide research category alongside Selank and Semax, which are studied for distinct but related neuropeptide-signalling pathways.

Velox Peptides supply information

Velox Peptides supplies DSIP as a lyophilised (freeze-dried) powder. Each batch is tested by HPLC (a lab method that measures how pure something is) and comes out at 98.7% pure or higher. A batch certificate of analysis (a lab report for that exact batch) is available if you ask. To mix the powder back into a liquid (called reconstituting it), see the reconstitution calculator. Sold only as a research reagent for in vitro (lab-only) use.

References & further reading

  1. “Evidence for a role of delta-sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat.” 1988. PMID: 3368469
  2. “The phosphorylated analogue of DSIP enhances slow-wave sleep and paradoxical sleep in unrestrained rats.” 1989. PMID: 2496423
  3. “The hypnogenic effects of DSIP analogues: a comparative study in rabbits and rats.” 1992. PMID: 1455954
  4. Graf MV, Kastin AJ. “Delta-sleep-inducing peptide (DSIP): a review.” Neuroscience & Biobehavioral Reviews, 1984.
  5. Kovalzon VM, Strekalova TV. “Delta sleep-inducing peptide (DSIP): a still unresolved riddle.” Journal of Neurochemistry, review literature.

Summaries are paraphrased from the peer-reviewed literature. For full source citations, email veloxpeps@gmail.com.

Frequently asked questions

What is DSIP?
DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide studied for its association with delta-wave sleep modulation. Velox Peptides supplies it as a research reagent for in vitro use only.
What is DSIP studied for?
In preclinical models DSIP is studied for its association with sleep architecture (especially slow-wave sleep) and with stress-response attenuation.
What purity is Velox Peptides DSIP?
DSIP is HPLC-verified at a minimum of 98.7% purity, with batch documentation available on request.
What is the amino-acid sequence of DSIP?
DSIP is the nonapeptide Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, an endogenous peptide first isolated during sleep-induction experiments.
Is the receptor for DSIP known?
No — despite decades of research, DSIP’s precise receptor and mechanism remain incompletely defined, which is part of why it is still studied.
Is DSIP legal to buy in the UK?
Yes — for in vitro research purposes. Velox Peptides supplies it solely as a research reagent, not for human or veterinary use.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.

All research summaries on this page are derived from publicly available peer-reviewed literature. Velox Peptides makes no therapeutic claims. For research use only.